<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Urologiia</journal-id><journal-title-group><journal-title xml:lang="en">Urologiia</journal-title><trans-title-group xml:lang="ru"><trans-title>Урология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1728-2985</issn><issn publication-format="electronic">2414-9020</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">680377</article-id><article-id pub-id-type="doi">10.18565/urology.2024.6.118-121</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Clinical case</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Наблюдения из практики</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">A clinical case of bladder metastasis of skin melanoma</article-title><trans-title-group xml:lang="ru"><trans-title>Клиническое наблюдение метастатического поражения мочевого пузыря при меланоме кожи</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2798-368X</contrib-id><name-alternatives><name xml:lang="en"><surname>Aboyan</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Абоян</surname><given-names>И. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Ph.D., MD, professor</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор, главный врач</p></bio><email>aboyan@center-zdorovie.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pakus</surname><given-names>D. I.</given-names></name><name xml:lang="ru"><surname>Пакус</surname><given-names>Д. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Ph.D., Chief</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, главный врач</p></bio><email>sergejj.pakus@rambler.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6468-5983</contrib-id><name-alternatives><name xml:lang="en"><surname>Pakus</surname><given-names>S. M.</given-names></name><name xml:lang="ru"><surname>Пакус</surname><given-names>С. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Ph.D., head of the oncourology Department</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, заведующий отделением онкоурологии</p></bio><email>sergejj.pakus@rambler.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2752-4395</contrib-id><name-alternatives><name xml:lang="en"><surname>Shiranov</surname><given-names>K. A.</given-names></name><name xml:lang="ru"><surname>Ширанов</surname><given-names>К. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Ph.D., urologist at the Department of urology</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, врач-уролог</p></bio><email>urologgg@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lemeshko</surname><given-names>S. I.</given-names></name><name xml:lang="ru"><surname>Лемешко</surname><given-names>С. И.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Ph.D., Head of the Department of Pathology of Central Diagnostic Laboratory</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, заведующая отделом патологоанатомических исследований</p></bio><email>sergejj.pakus@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">CDC «Zdorovie»</institution></aff><aff><institution xml:lang="ru">ГБУ РО КДЦ «Здоровье»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">GBU RO Oncologic dispensary</institution></aff><aff><institution xml:lang="ru">ГБУ РО «Онкодиспансер» г. Ростова-на-Дону</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">CDC «Zdorovie»</institution></aff><aff><institution xml:lang="ru">ГБУ РО КДЦ «Здоровье» г. Ростова-на-Дону</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-12-10" publication-format="electronic"><day>10</day><month>12</month><year>2024</year></pub-date><issue>6</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>115</fpage><lpage>118</lpage><history><date date-type="received" iso-8601-date="2025-05-24"><day>24</day><month>05</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-05-24"><day>24</day><month>05</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, ООО «Бионика Медиа»</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/1728-2985/article/view/680377">https://journals.eco-vector.com/1728-2985/article/view/680377</self-uri><abstract xml:lang="en"><p>Melanoma is the most aggressive malignant skin neoplasm with a high potential for metastasis and molecular genetic diversity.</p> <p>A clinical case of a 35-year-old patient who admitted to the clinic with a diagnosis of melanoma of the skin on the back of pT2aN2M1b, Clarke invasion stage 3, BRAF (+), metastases to the brain, spine (Th8), who had previously undergone to complete excision of melanoma in 2023, is presented in the article. During examination, bladder tumor was detected. Histological study confirmed the presence of metastatic melanoma of the bladder.</p> <p>Metastatic bladder tumor in patients with melanoma is a rare entity. Surgical treatment can be carried out to improve dysuria and the oncological outcomes, including those patients with synchronous metastases.</p></abstract><trans-abstract xml:lang="ru"><p>Меланома – наиболее опасное злокачественное новообразование кожи с высоким потенциалом к метастазированию и молекулярно-генетическим разнообразием.</p> <p>В статье представлено клиническое наблюдение пациентки 35 лет, которая обратилась в клинику с диагнозом: меланома кожи спины pT2aN2M1b, St. IB, клиническая группа 2, инвазия по Кларку 3 ст., BRAF (+), метастазы в головной мозг, позвоночник (Th8), состояние после иссечения меланомы R0 (2023 г.). При обследовании больной выявлено образование мочевого пузыря. При гистологическом исследовании подтверждено наличие метастатической меланомы мочевого пузыря.</p> <p>Метастатическое поражение мочевого пузыря у пациентов с меланомой является редким клиническим наблюдением. Оперативное лечение может проводиться с целью купирования дизурии и улучшения прогноза течения онкологического процесса, в том числе у больных с синхронными метастазами.</p></trans-abstract><kwd-group xml:lang="en"><kwd>bladder melanoma</kwd><kwd>melanoma</kwd><kwd>transurethral laser resection of the bladder tumor</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>меланома мочевого пузыря</kwd><kwd>меланома</kwd><kwd>лазерная резекция мочевого пузыря</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Bakhareva Yu.O., Tarakanova V.O., Rubanyak M.Yu., Kamenskikh E.M. Skin melanoma (C43): analysis of morbidity and mortality trends in the light of the COVID-19 pandemic, molecular epidemiology. Issues of oncology. 2023;69(4):631–638. https://doi.org/10.37469/0507-3758-2023-69-4-631-638. Russian (Бахарева Ю.О., Тараканова В.О., Рубаняк М.Ю., Каменских Е.М. Меланома кожи (C43): анализ тенденций заболеваемости и смертности в свете пандемии COVID-19, молекулярная эпидемиология. Вопросы онкологии. 2023;69(4):631–638. https://doi.org/10.37469/0507-3758-2023-69-4-631-638).</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Meunier R., Pareek G., Amin A. Metastasis of Malignant Melanoma to Urinary Bladder: A Case Report and Review of the Literature. Case Rep Pathol. 2015;2015:173870. doi: 10.1155/2015/173870.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Weston P.A., Smith B.J. Metastatic melanoma in the bladder and urethra. The British Journal of Surgery. 1964;51:78–79. doi: 10.1002/bjs.1800510115.).</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Das Gupta T., Brasfield R. Metastatic melanoma. A clinicopathological study. Cancer. 1964;17:1323–1339. doi: 10.1002/1097-0142(196410)17: 1060;1323::aid-cncr282017101562;3.0.co;2-n.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Bates A.W., Baithun S.I. Secondary neoplasms of the bladder are histological mimics of nontransitional cell primary tumours: clinicopathological and histological features of 282 cases. Histopathology. 2000;36(1):32–40. doi: 10.1046/j.1365-2559.2000.00797.x.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Meunier R., Pareek G., Amin A. Metastasis of Malignant Melanoma to Urinary Bladder: A Case Report and Review of the Literature. Case Rep Pathol. 2015;2015:173870. doi: 10.1155/2015/173870.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Efesoy O., Cayan S. Bladder metastasis of malignant melanoma: a case report and review of literature. Med Oncol. 2011;28 Suppl 1:S667–69. doi: 10.1007/s12032-010-9730-x.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Topal C.S., Kır G., Daş T., Sarbay B., Tosun M.İ. Metastatic malignant melanoma of the urinary bladder: A case report and review of the literature. Indian J Pathol Microbiol. 2016;59(4):532–534. doi: 10.4103/0377-4929.191820.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Gupta R., Bhatti S.S., Dinda A.K., et al. Primary melanoma of the urethra: a rare neoplasm of the urinary tract. Int Urol Nephrol. 2007, 39:833–886.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Patil R.V., Woldu S.L., Lucas E., et al. Metastatic melanoma to the bladder: case report and review of the literature. Urol Case Rep. 2017;11:33–36.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Aggarwal P., Knabel P., Fleischer A.B., Jr. J Am Acad Dermatol; 2021. United States Burden of Melanoma and Non-melanoma Skin Cancer from 1990 to 2019.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Holmberg C.J., Katsarelias D., Jespersen H., et al. Surgery of metastatic melanoma after systemic therapy – the SUMMIST trial: study protocol for a randomized controlled trial. Acta Oncol. 2021;60(1):52–55.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Hamid O., Robert C., Daud A., et al. Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001. Ann Oncol. 2019;30(4):582–588.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Kumar R.A., Batra N., Frankel J., Kumar U. Melanoma metastasis to the bladder: A case report. Urol Case Rep. 2021;40:101941. doi: 10.1016/j.eucr.2021.101941.</mixed-citation></ref></ref-list></back></article>
